Last reviewed · How we verify
LT Adjuvant Patch — Competitive Intelligence Brief
phase 2
Biologic
Live · refreshed every 30 min
Target snapshot
LT Adjuvant Patch (LT Adjuvant Patch) — Intercell USA, Inc..
Comparator set
| Drug | Generic | Sponsor | Phase | Class | Target | Approval / PDUFA |
|---|---|---|---|---|---|---|
| LT Adjuvant Patch TARGET | LT Adjuvant Patch | Intercell USA, Inc. | phase 2 |
Recent regulatory actions (last 90 days)
Upcoming PDUFA dates (next 180 days)
Patent timeline (forward window)
Sponsor landscape
Subscribe to ongoing alerts
Push every new event for this competitive set into your RSS reader, IFTTT/Zapier workflow, or email digest:
- LT Adjuvant Patch CI watch — RSS
- LT Adjuvant Patch CI watch — Atom
- LT Adjuvant Patch CI watch — JSON
- LT Adjuvant Patch alone — RSS
Cite this brief
Drug Landscape (2026). LT Adjuvant Patch — Competitive Intelligence Brief. https://druglandscape.com/ci/lt-adjuvant-patch. Accessed 2026-05-13.
Build your own brief
Pick any drug + add comparators:
https://druglandscape.com/ci/{slug}— auto-detected competitorshttps://druglandscape.com/ci/{slug}?vs=drug1,drug2,drug3— explicit comparators- Brand names auto-resolve:
/ci/keytruda→ 301 →/ci/pembrolizumab